Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

ISE Chemicals Corporation (4107.T)

Compare
19,750.00
+1,580.00
+(8.70%)
At close: 3:30:00 PM GMT+9
Loading Chart for 4107.T
  • Previous Close 18,170.00
  • Open 20,800.00
  • Bid 19,750.00 x --
  • Ask 19,800.00 x --
  • Day's Range 19,540.00 - 20,800.00
  • 52 Week Range 15,980.00 - 40,500.00
  • Volume 63,200
  • Avg. Volume 84,308
  • Market Cap (intraday) 100.647B
  • Beta (5Y Monthly) -0.06
  • PE Ratio (TTM) 19.83
  • EPS (TTM) 995.72
  • Earnings Date Apr 30, 2025
  • Forward Dividend & Yield 380.00 (1.89%)
  • Ex-Dividend Date Jun 27, 2025
  • 1y Target Est --

ISE Chemicals Corporation engages in the iodine and natural gas, and metallic compound businesses in Japan. The company offers iodine products, such as ISEFLO, a prilled iodine; crude iodine; potassium, sodium, and cuprous iodide, as well as hydroiodic acid; and iodine disinfectants under the ISEPHOR, DIASAN CLEAN, and ISEPHOR L names. It also provides metallic compounds, including nickel chloride, cobalt chloride, and tricobalt tetraoxide; and extracts and supplies natural gas to gas companies and factories. The company was founded in 1927 and is headquartered in Tokyo, Japan. ISE Chemicals Corporation is a subsidiary of AGC Inc.

www.isechem.co.jp

310

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4107.T

View More

Performance Overview: 4107.T

Trailing total returns as of 4/10/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4107.T
39.14%
Nikkei 225 (^N225)
13.25%

1-Year Return

4107.T
22.50%
Nikkei 225 (^N225)
12.56%

3-Year Return

4107.T
395.45%
Nikkei 225 (^N225)
28.25%

5-Year Return

4107.T
691.37%
Nikkei 225 (^N225)
77.50%

Compare To: 4107.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4107.T

View More

Valuation Measures

Annual
As of 4/9/2025
  • Market Cap

    92.60B

  • Enterprise Value

    84.47B

  • Trailing P/E

    18.26

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.78

  • Price/Book (mrq)

    2.60

  • Enterprise Value/Revenue

    2.54

  • Enterprise Value/EBITDA

    9.00

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.23%

  • Return on Assets (ttm)

    11.22%

  • Return on Equity (ttm)

    15.03%

  • Revenue (ttm)

    33.29B

  • Net Income Avi to Common (ttm)

    5.07B

  • Diluted EPS (ttm)

    995.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.69B

  • Total Debt/Equity (mrq)

    1.57%

  • Levered Free Cash Flow (ttm)

    469.62M

Research Analysis: 4107.T

View More

Company Insights: 4107.T

Research Reports: 4107.T

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.